ÂÜÀòÂÒÂ×

Stephen Thatch has extensive experience in the pharmaceutical and healthcare sectors, currently serving as an Account Manager at Recordati Rare Diseases Inc. since December 2020. Previously, Stephen held the role of Hyperkalemia Specialist at ZS Pharma, Inc., where contributions included launching a new hyperkalemia medication to the Nephrology and Cardiology markets. Prior to that, Stephen worked at Boston Heart Diagnostics as Director of Strategic Accounts, focusing on sales strategies for corporate wellness programs. In earlier positions, Stephen was National Director of Business Development at Cleveland HeartLab, Inc., and held roles at Gilead Sciences and Kos Pharmaceuticals, contributing to the launch and promotion of various cardiovascular and cholesterol medications. Stephen's academic background includes a BA in Interdisciplinary Studies from the University of South Carolina and coursework toward a Master of Sport Science from the United States Sports Academy.